IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enavate Sciences GP, LLC

Q4 2025 Holdings

Filed 2026-02-17 | 7 holdings | $506.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Zenas Biopharma Inc(ZBIO)COM98937L105$142.3M3,919,15928.1%
Immunome Inc(IMNM)COM45257U108$102.4M4,768,58320.2%
Sionna Therapeutics Inc(SION)COM829401108$101.9M2,478,03020.1%
Upstream BIO Inc(UPB)COM91678A107$66.8M2,459,70313.2%
Compass Therapeutics Inc(CMPX)COM20454B104$41.8M7,788,1508.3%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$32.9M2,626,9466.5%
Camp4 Therapeutics Corp(CAMP)COM13463J101$18.6M3,035,8253.7%